Prognostic Impacts of LL-37 in Relation to Lipid Profiles of Patients with Myocardial Infarction: A Prospective Cohort Study

Background. In vivo studies show that LL-37 inhibits the progression of atherosclerosis and predicts a lower risk of recurrent ischemia in patients with acute myocardial infarction (AMI), which could be mediated by the modulation of lipid metabolism. The current study aimed to investigate the effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Runzhen, Zhao, Hanjun, Zhou, Jinying, Wang, Ying, Li, Jiannan, Zhao, Xiaoxiao, Li, Nan, Liu, Chen, Zhou, Peng, Chen, Yi, Song, Li, Yan, Hongbing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599865/
https://www.ncbi.nlm.nih.gov/pubmed/36291690
http://dx.doi.org/10.3390/biom12101482

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599865/
https://www.ncbi.nlm.nih.gov/pubmed/36291690
http://dx.doi.org/10.3390/biom12101482

Ejemplares similares